Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Plasma cell 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia, Myeloid, Acute 22Leukemia, Lymphocytic, Chronic, B-Cell 20Hodgkin Disease 19Lymphoma, Non-Hodgkin 16Lymphoma, Mantle-Cell 14Myelodysplastic Syndromes 13Myeloproliferative Disorders 12Lymphoma, Large B-Cell, Diffuse 12Multiple Myeloma 11Leukemia, Prolymphocytic 10Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Chronic-Phase 10Waldenstrom Macroglobulinemia 9Lymphoma, Follicular 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Lymphoma 8Burkitt Lymphoma 8Myelodysplastic-Myeloproliferative Diseases 6Primary Myelofibrosis 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large-Cell, Anaplastic 5Leukemia, Biphenotypic, Acute 5Graft vs Host Disease 5Congenital Abnormalities 5Blast Crisis 5Anemia, Refractory, with Excess of Blasts 5Sezary Syndrome 4Mycosis Fungoides 4

Interventions

fludarabine phosphate 6Cyclophosphamide 6Whole-Body Irradiation 4Mycophenolic Acid 4fludarabine 3Thiotepa 3Methotrexate 3Cyclosporine 3Tacrolimus 2Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2Dexamethasone 2Cyclosporins 2Calcium Dobesilate 2tagraxofusp 1merphos 1lorvotuzumab mertansine 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1X-Rays 1Vincristine 1Sirolimus 1Salvia hispanica seed extract 1Rituximab 1Ranitidine 1Nivolumab 1Mesna 1Magnetic Resonance Spectroscopy 1MK 2206 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Blastic Plasmacytoid Dendritic Cell Neoplasm × Cyclosporins × Lymphoid × Clear all
NCT03246906 2026-05-14

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Fred Hutchinson Cancer Center

Phase 2 Terminated
150 enrolled 18 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Blastic Plasmacytoid Dendritic Cell Neoplasm, Hematologic Diseases, Hodgkin Disease, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT06013423 2026-01-22

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Fred Hutchinson Cancer Center

Phase 2 Recruiting
54 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡